Streetbeat News

Analyst Ratings

DBD

Wedbush analyst Matt Bryson has reiterated an Outperform rating for Diebold Nixdorf (NYSE:DBD) and maintained a $50 price target.

Portfolio Pulse from Benzinga Newsdesk

September 12, 2024 | 12:30 pm

APA

Evercore ISI Group has maintained an 'In-Line' rating for APA Corporation with a price target of $39, as per analyst Stephen Richardson.

Portfolio Pulse from Benzinga Newsdesk

September 12, 2024 | 12:30 pm

FDX

Evercore ISI Group has maintained an 'Outperform' rating on FedEx but has slightly lowered the price target from $339 to $335.

Portfolio Pulse from Benzinga Newsdesk

September 12, 2024 | 12:28 pm

CPB

Barclays analyst Andrew Lazar maintains an Underweight rating on Campbell Soup (NASDAQ:CPB) but raises the price target from $45 to $49.

Portfolio Pulse from Benzinga Newsdesk

September 12, 2024 | 12:26 pm

MU

Raymond James analyst Srini Pajjuri maintains an Outperform rating on Micron Technology but lowers the price target from $160 to $125.

Portfolio Pulse from Benzinga Newsdesk

September 12, 2024 | 12:25 pm

ICUI

Raymond James analyst Jayson Bedford has maintained an 'Outperform' rating on ICU Medical (NASDAQ:ICUI) and raised the price target from $158 to $190.

Portfolio Pulse from Benzinga Newsdesk

September 12, 2024 | 12:24 pm

AAOI

Rosenblatt analyst Mike Genovese has maintained a Buy rating on Applied Optoelectronics (NASDAQ:AAOI) and increased the price target from $15 to $20.

Portfolio Pulse from Benzinga Newsdesk

September 12, 2024 | 12:22 pm

AAP

ALC

AMT

ARMK

DCBO

DPZ

EXAS

RNXT

TIL

TRU

Top Wall Street analysts have updated their price targets for several companies, including Exact Sciences, Docebo, RenovoRx, Instil Bio, Domino's Pizza, Aramark, TransUnion, Advance Auto Parts, American Tower, and Alcon. Notably, Exact Sciences saw a significant price target increase from Piper Sandler, leading to a 9.8% rise in its stock price.

Portfolio Pulse from Avi Kapoor

September 12, 2024 | 12:21 pm

ALLY

RBC Capital analyst Jon Arfstrom maintains an Outperform rating on Ally Financial but lowers the price target from $49 to $40.

Portfolio Pulse from Benzinga Newsdesk

September 12, 2024 | 12:21 pm